Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
from NYT > Health https://ift.tt/j4Eae0u
via IFTTT
from NYT > Health https://ift.tt/j4Eae0u
via IFTTT

No comments